Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark Exemplified by treatment initiation with an ACE inhibitor or an angiotensin-II receptor antagonist

Scandinavian Journal of Primary Health Care

Volumn 27, Issue 4, 2009, Pages 223-231

  Juul, Lise ^a   Sandbaek, Annelli ^a   Foldspang, Anders ^a   Frydenberg, Morten ^a   Borch Johnsen, Knut ^a,b   Lauritzen, Torsten ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

ACE inhibitors; Family practice; General practice; Guideline adherence; Patient compliance; Screening; Type 2 diabetes mellitus

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENMARK; DIASTOLIC BLOOD PRESSURE; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROGNOSIS; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE DETERMINATION; DENMARK; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 72449135367     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.3109/02813430903279117     Document Type: Article

References (20)

1. Laakso M. Dyslipidemia, morbidity, and mortality in noninsulin- dependent diabetes mellitus: Lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1997;11:137-141
2. Spijkerman AM, Adriaanse MC, Dekker JM, et al. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 2002;25:1784-1789
3. Borch-Johnsen K. Type 2 diabetes. Prevention of a public disease and its consequences. Ugeskr Laeger 2004;166: 1316-1320
4. Glumer C, J orgensen T, B orch-Johnsen K, Inter99 study. Prevalences of diabetes and impaired glucose regulation in a Danish population: The Inter99 study. Diabetes Care 2003; 26:2335-2340
5. Wilson JMG, Jungner G. Principles and practice of screening for disease Geneva. World Health Organization ; 1968.
6. Faber OK, S andahl Christiansen J. I kke-insulinkrævende diabetes - NIDDM (Non-insulin-dependent diabetes mellitus - NIDDM). Copenhagen: Danish College of General Practitioners; 1998 (in Danish).
7. Type 2 diabetes i almen praksis. Diagnose og behandling (Type 2 diabetes in general practice. Diagnosis and treatment). Copenhagen: Danish College of General Practitioners ; 2002 (in Danish).
8. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000; 355:253-259
9. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393
10. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002;61:1086-1097
11. Lauritzen T, G riffi n S, B orch-Johnsen K, W areham NJ, Wolffenbuttel BH, Rutten G, et al. The ADDITION study: Proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000;24:6-11.
12. Christensen JO, Sandbaek A, L auritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 2004;47:1566-1573
13. Bjørner JB. Dansk manualtil SF-36. (Danish manual to SF-36). Lif; 1997 (in Danish)
14. Manyemba J, Mangoni AA, Pettingale KW, J ackson SH. Determinants of failure to prescribe target doses of angiotensin-converting enzyme inhibitors for heart failure. Eur J Heart Fail 2003;5:693-696
15. Kasje WN, D enig P, Stewart RE, d e Graeff PA, Haaijer-Ruskamp FM. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: A multilevel study. Eur J Clin Pharmacol 2005;61:145-151
16. Midlov P, Ekesbo R, Johansson L, Gerward S, Persson K, Nerbrand C, et al. Barriers to adherence to hypertension guidelines among GPs in southern Sweden: A survey. Scand J Prim Health Care 2008;26:154-159
17. Olivarius Nde F. Diabetes care today: Not everyone should have intensive multipharmacological treatment. Scand J Prim Health Care 2004;22:67-70.
18. Zoffmann V, Harder I, Kirkevold M. A person-centered communication and reflection model: Sharing decision-making in chroniccare. Qual Health Res 2008;18:670-685
19. Aspinwall LG, Taylor SE. A stitch in time: Selfregulation and proactive coping. Psychol Bull 1997; 121:417-436
20. Holmstrom IM, Rosenqvist U. Misunderstandings about illness and treatment among patients with type 2 diabetes. J Adv Nurs 2005;49:146-154